Last reviewed · How we verify
Placebo for ABT-333 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for ABT-333 (Placebo for ABT-333) — AbbVie (prior sponsor, Abbott). A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for ABT-333 TARGET | Placebo for ABT-333 | AbbVie (prior sponsor, Abbott) | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for ABT-333 CI watch — RSS
- Placebo for ABT-333 CI watch — Atom
- Placebo for ABT-333 CI watch — JSON
- Placebo for ABT-333 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for ABT-333 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-abt-333. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab